Your search history is turned on.
Date: May 1, 2024 Jurisdictions: All jurisdictions
IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET TORONTO and GLIL YAM, Israel, May 1, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will...
Date: April 16, 2024 Jurisdictions: All jurisdictions
IMC to transfer its Oranim Pharmacy shares back to the seller IMC to transfer its Oranim Pharmacy shares back to the seller TORONTO and GLIL YAM, Israel, April 16, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Comp...
Date: April 9, 2024 Jurisdictions: All jurisdictions
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market TORONTO and GLIL YAM, Israel, April 9, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany...
Date: April 4, 2024 Jurisdictions: All jurisdictions
Avant and IMC Execute BLK MKT Trademark Licensing Agreement for the German Medical Cannabis Market Avant and IMC Execute BLK MKT Trademark Licensing Agreement for the German Medical Cannabis Market TORONTO, GLIL YAM, Israel and KELOWNA, BC., April 4, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations...
Date: April 1, 2024 Jurisdictions: All jurisdictions
IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients With the implementation of the anticipated medical cannabis regulatory reform, the Israeli ministry of health removed many of the heavy regulations in the ...
Date: March 28, 2024 Jurisdictions: All jurisdictions
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR TRANSITION R...
Date: March 28, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, BIRENBERG, Uri, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonabl...
IM Cannabis Reports 2023 Financial Results IM Cannabis Reports 2023 Financial Results TORONTO and GLIL YAM, Israel, March 28, 2024 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial and operational results for the year ended December 31, 2023, the highlights of which are included in this news release. All ...
1 Form 52-109F1 Certification of Annual Filings Full Certificate I, Uri Birenberg, the Chief Financial Officer of IM Cannabis Corp., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in t...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...